1. Introduction {#sec1}
===============

Coronary heart disease (CHD) is a complex disease caused by an insufficient blood flow inside the coronary vessels \[[@B1]\]. The blockage of the arteries is often caused by the plaque accumulated in the wall of arteries. The plaque is formed by excess low density lipoprotein cholesterol (LDL-C) in blood that dramatically increases the risk of CHD \[[@B2]\]. Low density lipoprotein receptor (LDLR) plays a key role in the regulation of cholesterol metabolism by removing excess LDL-C in blood \[[@B3], [@B4]\].

CHD is caused by both environmental and genetic factors \[[@B5]\]. Variations of genes involved in lipoprotein and lipid metabolism are playing an important role in the susceptibility of CHD \[[@B6]\].*LDLR* gene mutations can lead to deficiency or abnormality of LDLR in the cell membrane surface and thus disrupt lipid metabolism \[[@B4]\].*LDLR* gene mutations are known to cause familial hypercholesterolemia (FH) \[[@B2]\] that is an important risk factor of CHD and other atherosclerotic diseases \[[@B7]\]. Recent genome-wide association studies (GWASs) showed that*LDLR* gene mutations were significantly associated with the abnormal blood lipid levels and CHD \[[@B8], [@B9]\]. Among the*LDLR*polymorphisms, rs2228671 was associated with LDL-C levels and CHD in German and British populations \[[@B10]--[@B14]\]. However, discrepancies were also shown in the association of*LDLR*rs2228671 with CHD in Italians and Germans \[[@B15], [@B16]\].

Meta-analysis is able to combine and review the results from previous studies \[[@B17], [@B18]\]. Meta-analysis improves the power of comprehensive statistics by pooling the data from different studies. In the present study, we performed a meta-analysis of*LDLR*rs2228671 polymorphism with CHD among 17299 individuals in 8 studies.

2. Material and Methods {#sec2}
=======================

2.1. Retrieval of Studies and Selection Criteria {#sec2.1}
------------------------------------------------

We systematically search available studies from 2003 to 2013 in PubMed (English), CNKI, and Wanfang (Chinese). Keywords were "coronary heart disease" or "coronary artery disease" or "myocardial infarction" combined with "*LDLR*" or "low density lipoprotein receptor" or "rs2228671" and "polymorphism" or "genetic association." The inclusion criteria for the studies involved in this meta-analysis met the following criteria: (1) case-control study about*LDLR* rs2228671 polymorphism; (2) case-control study with genotyping or allelic information, or odd ratio (OR) with 95% confidential interval (CI).

2.2. Data Extraction {#sec2.2}
--------------------

Data included in this meta-analysis was extracted independently from all studies using the same standard protocol by two reviewers (HY and YH). The inclusion criteria of our meta-analysis were as follows: first author\'s name, publication year, ethnicity, numbers of cases and controls, genotype distribution, and OR with 95% CI.

2.3. Patients and Controls {#sec2.3}
--------------------------

The study protocol was approved by the ethical committee of School of Medicine, Ningbo University. A total of 162 cases and 113 controls were recruited in this study from the Affiliated Hospital of Ningbo University. All the participants in this study have signed the informed consent forms. All the 275 individuals underwent coronary angiography and were categorized into CHD patients and non-CHD controls according to our previous descriptions \[[@B5], [@B19]\]. All the participants enrolled in this study were Han Chinese residing in or near Ningbo city. None of individuals in this study had congenital heart disease, cardiomyopathy and severe liver, or kidney disease.

2.4. SNP Genotyping {#sec2.4}
-------------------

Genomic DNA was isolated from peripheral blood lymphocytes using standard phenol-chloroform method and then was stored in TE buffer. All DNA samples were amplified by polymerase chain reaction (PCR). PCR was denatured at 94°C for 15 s, followed by 45 cycles of denaturation at 94°C for 20 s, annealing for 30 s at 56°C, extension at 72°C for 1 min, and a final extension at 72°C for 3 min. DNA amplification and genotyping was performed on the SEQUENOM Mass-ARRAY iPLEX platform according to the manufacturer\'s instructions \[[@B5]\].

2.5. Statistical Analyses {#sec2.5}
-------------------------

Hardy-Weinberg equilibrium (HWE) was examined by the Arlequin program (version 3.5) \[[@B20]\]. The differences in the genotype and allele frequencies between cases and controls were analyzed by the CLUMP22 software with 10,000 Monte Carlo simulations \[[@B21]\]. Power analysis was performed by Power and Sample Size Calculation software \[[@B22]\]. Meta-analysis was made by REVMAN 5.0 (Cochrane Collaboration, Oxford, United Kingdom) and Strata 11.0 software (Strata Corporation, College Station, TX) \[[@B23], [@B24]\]. Publication bias was evaluated by Begg and Egger regression tests \[[@B25]\]. The combined ORs with 95% CI values were calculated by either fixed-effect or random-effect method \[[@B26]\]. A two-tailed *P* value of 0.05 or lower was defined to be statistically significant.

3. Results {#sec3}
==========

We systematically searched in PubMed, CNKI, and Wanfang from 2003 to 2013, and selected a total of 57 literatures after removing the duplicated publications ([Figure 1](#fig1){ref-type="fig"}). According to the descriptions in the titles and abstracts, we excluded 26 irrelevant literatures, 6 literatures on other variants, and 12 literatures on other diseases. In addition, 1 literature without sufficient case-control genotyping data and 5 literatures without detailed SNP information were also removed. At last, 6 literatures \[[@B11]--[@B16]\] on 7 case-control studies were harvested in our meta-analysis ([Table 1](#tab1){ref-type="table"}). Furthermore, we performed a case-control study in Han Chinese population, and it was later included in our meta-analysis.

Genotype distribution of rs2228671 in our case-control study met HWE for both CHD cases and non-CHD controls (*P* \> 0.05), indicating that our case-control study had a well-characterized random sampling. Our case-control study suggested that*LDLR* rs2228671-T allele was rare in Chinese population (cases: 2%; controls: 1%), and this agrees with the frequency in HapMap Chinese Han in Beijing (CHB) population (0--2%). No significant difference in the genotype distribution between CHD cases and non-CHD controls are revealed in all samples (*P* \> 0.05; [Table 2](#tab2){ref-type="table"}) and in the subgroup analysis by gender (*P* \> 0.05; [Table 2](#tab2){ref-type="table"}). In summary, our case-control study showed that there was no association between*LDLR* rs2228671 and CHD in Chinese. However, significant association was found between*LDLR* rs2228671 and CHD in European population (*χ* ^2^ = 20.59, *P* \< 0.0001 by genotype; *χ* ^2^ = 20.26; OR = 1.180, 95% CI = 1.098--1.269, *P* \< 0.0001 by allele; [Table 3](#tab3){ref-type="table"}). Using the fixed-effect method, our meta-analysis contained 7,588 CHD patients and 9,711 controls from German, British, Italian, and Chinese populations. As shown in [Figure 2](#fig2){ref-type="fig"}, significant association was observed between rs2228671 and CHD (*P* = 0.0005, OR = 0.83, and 95% CI = 0.75--0.92). In addition, no heterogeneity among the studies was included in this meta-analysis (*I* ^2^ = 0%; [Figure 2](#fig2){ref-type="fig"}). Furthermore, no obvious visual evidence of publication bias in the meta-analysis was shown by funnel plot (*P* \> 0.05; [Figure 3](#fig3){ref-type="fig"}).

4. Discussion {#sec4}
=============

Aberrant LDLR level in blood can cause abnormal cholesterol metabolism \[[@B2]\]. As the main pathogenic gene of FH,*LDLR* gene is associated with multiple vascular diseases \[[@B15], [@B16], [@B27]\]. Polymorphisms of*LDLR* gene were associated with type 2 diabetes \[[@B28]\] and hypertension \[[@B29]\] that also related to CHD. Recently, a handful of*LDLR* polymorphisms have been studied in CHD, including those (rs14158, rs3826810, rs1433099, rs2738464, rs2738465, and rs2738466) in the 3′-untranslated region (3′-UTR) and rs2228671 in second exon \[[@B30]--[@B32]\]. SNPs in first intron (rs6511720) and 5′ flanking region (rs17248720) of*LDLR* gene were closely related to both LDL-C and CHD \[[@B33], [@B34]\]. Rs1433099 and rs2738466 in the 3′-UTR of*LDLR* were reported to be associated with baseline lipids in American population \[[@B32]\]. The T allele of rs2228671 polymorphism was associated with higher FVIII:c levels. In addition, LDLR rs2228671 may be regulated FVIII:c levels and associated with the independence risk factor (plasma lipids) of CHD \[[@B16]\].

Our meta-analysis among 17299 individuals showed that rs2228671-T allele reduced the risk of coronary heart disease in the combined samples from German, British, Italian, and Chinese populations (OR = 0.83, *P* = 0.0005). Furthermore, rs2228671-T allele frequencies in the meta-analysis among German, British, and Italian populations were 7--12.2% that is similar to 10% in HapMap CEU population. However, rs2228671-T allele frequency is 0% in HapMap CHB population and 0.9% in the controls of our study. Due to the rare allele of*LDLR* rs2228671 in our samples, the power of our case-control study was only 5.1%, in contrast of 100% in the present meta-analysis. This suggests that a lack of association in our case-control study may largely be explained by the insufficient power for this rare polymorphism and the small sample size. Future investigation on other common*LDLR*polymorphisms is worth being performed in a large Chinese cohort.

Human*LDLR* is about 43 kb in length and has 1367 active polymorphism. As shown in our study, the allele frequency of rs1122608-T is much lower than those in the European studies; suggesting a cross-population comparison of this polymorphism may help one understand the role of*LDLR* in different ethnic population. Meanwhile, the previous tested*LDLR* rs1122608 polymorphism did not yield a significant result (*P* = 0.148) \[[@B35]\], in contrast to a significant result of rs2228671 in the current study (*P* = 0.0005). This suggests rs2228671 and rs1122608 might exert different contributions to the risk of CHD.

There were several limitations in our study as follows. Firstly, most of the involved individuals in our meta-analysis were Europeans; thus our result might not be applied to other populations such as Chinese. Secondly, although we had no evidence of the publication bias in our meta-analysis, we cannot exclude the possibility of existing potential bias upon reporting the studies without significant association results. Last but not least, the power of our case-control study in Chinese is only 5.1%. The negative result of rs2228671 might not represent for other variants of*LDLR*gene in Chinese population.

In conclusion, the meta-analysis demonstrated that the*LDLR* rs2228671-T allele is a protective factor of CHD in Europeans. However, the case-control study showed no significant association of*LDLR* rs2228671 with CHD in Han Chinese population.
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###### 

Characteristics of the association studies between rs2228671 and CHD.

  Author and year                       Ethnic group   Genotype (CC/CT/TT)   *P*-allele    
  ------------------------------------- -------------- --------------------- ------------- --------
  Ortlepp et al. (2003) \[[@B11]\]      German         937/216/10            972/255/22    0.0453
  Krawczak et al. (2006) \[[@B12]\]     German         1755/379/19           1840/474/25   0.0184
  Samani et al. (2007) \[[@B13]\]       German         781/93/1              1417/224/3    0.0281
  Samani et al. (2007) \[[@B13]\]       British        1578/322/13           2332/569/34   0.0051
  Schunkert et al. (2008) \[[@B14]\]    German         236/43/2              224/61/5      0.0343
  Erdmann et al. (2009) \[[@B15]\]      German         282/64/3              671/164/15    0.3333
  Martinelli et al. (2010) \[[@B16]\]   Italian        549/134/9             227/61/3      0.73
  Our study (2013)                      Chinese        157/4/1               111/2/0       0.485

###### 

Genotype and allele frequency distributionof*LDLR* gene rs2228671 polymorphism in cases and controls\*.

  Gender     Group     CC/CT/TT   *χ* ^2^   *P* (df = 2)   C/T     *χ* ^2^   *P* (df = 1)   OR (95% CI)
  ---------- --------- ---------- --------- -------------- ------- --------- -------------- -------------------
  All        Cases     157/4/1    0.86      1              318/6   0.87      0.49           0.47 (0.09--2.36)
  Controls   111/2/0   224/2                                                                
                                                                                            
  Male       Cases     113/2/1    0.51      0.77           228/4   NA        NA             0.49 (0.05--4.41)
  Controls   58/1/0    117/1                                                                
                                                                                            
  Female     Cases     44/2/0     0.53      0.76           90/2    NA        NA             0.42 (0.04--4.71)
  Controls   53/1/0    107/1                                                                

 \*NA represents not analyzed; rs2228671 meets HWE in all groups (*P* \> 0.05).

###### 

Genotype and allele frequency distributionof*LDLR* gene rs2228671 polymorphism in European population.

  Gender                Group           CC/CT/TT       *χ* ^2^   *P* (df = 2)   C/T          *χ* ^2^   *P* (df = 1)   OR (95% CI)
  --------------------- --------------- -------------- --------- -------------- ------------ --------- -------------- ----------------------
  European population   Cases           6218/1251/57   20.59     \<.0001        13687/1365   20.26     \<.0001        1.180 (1.098--1.269)
  Controls              7685/1808/107   17178/2022                                                                    
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